Skip to main content
SpringerLink
Log in

The Collection, Storage, Retrieval and Management of Adverse Drug Reaction Data and Adverse Event Data

  • Chapter
The Detection of New Adverse Drug Reactions

  • 17 Accesses

Abstract

Several aspects of the handling of adverse drug reaction (ADR) data and adverse event data are discussed in this chapter, including the sources of data, form design, computerisation and analysis of data. The published literature as a source of information about ADRs is also critically evaluated and the limitations of some literature-searching methods are identified. Coding systems for adverse events, diseases and drugs are also reviewed. The application of computer systems is discussed from the user’s view.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rogers, M.L. National abstracts: U.K. hospital pharmacists collaborative computerised database. In The Impact of Computer Technology on Drug Information (ed. P. Morrell and S.G. Johansson), North Holland, 1982, pp. 187–188

    Google Scholar 

  2. Rogers, M.L. The Pharmline drug information system. In Current Perspectives in Health Computing (ed. B. Kostrewski), British Computer Society, 1984, Cambridge University Press, pp. 135–140

    Google Scholar 

  3. Simkins, M.A. A comparison of databases for retrieving references to the literature on drugs. Information Processing and Management, 1977, 13, 141–153

    Article  Google Scholar 

  4. Anon. Adverse Drug Reactions Advisory Committee Report for 1978. Med. J. Aust., 1980, 1, 207–208

    Google Scholar 

  5. Morley, D. CAIRS. In Minis, Micros and Terminals for Libraries and Information Services (ed. A. Gilchrist), Haydon, 1981, pp. 78–79

    Google Scholar 

  6. Jones, J.K. Criteria for journal reports of suspected adverse drug reactions. Clin. Pharm., 1982, 1, 554–555

    Google Scholar 

  7. Berneker, G.C. et al. Standards for reporting adverse drug reactions, Br. Med. J., 1983, 287, 1720

    Article  Google Scholar 

  8. Helling-Borda, M., Manell, P. and Mandahl, H. Use of computers in drug monitoring. In Monitoring for Drug Safety, 2nd edition (ed. W.H.W. Inman), 1986, MTP Press, pp. 305–322

    Google Scholar 

  9. Wright, P. and Haybittle, J. Design of forms for clinical trials (1). Br. Med. J., 1979, 2, 529–530

    Article  Google Scholar 

  10. Idem, 1979, 2, 590–592

    Article  Google Scholar 

  11. Idem, 1979, 2, 650–651

    Article  Google Scholar 

  12. Rycroft, D. and Smith, D.E. Provision of poisons and safety data. Aslib Proc., 1980, 32(5), 235–240

    Article  Google Scholar 

  13. Talbot, J.C.C. Management of ADR data from different sources. Drug Inf. J., 1986, 20 297–299

    Google Scholar 

  14. Ravenscroft, T. and Smith, D.E. The development of Clindata. A clinical trial management system. J. Inf. Sci., 1981, 3, 129–136

    Article  Google Scholar 

  15. Teal, T.W. and Dimmig, A.L. Adverse drug experience management — A brief review of the McNeil Pharmaceutical system. Drug Inf. J., 1985, 19, 17–25

    Google Scholar 

  16. Fisher, M.P. Adverse reaction reporting. Clin. Res. Practices and Drug Reg. Affairs, 1986, 4, 329–343

    Article  Google Scholar 

  17. Herman, R.L. and Jargus, L.Y. Computer generation of the FDA 1639 form. Clin. Res. Practices and Drug Reg. Affairs, 1983, 1, 209–225

    Article  Google Scholar 

  18. Goldsmith, D.I. et al. A comprehensive system for international pharmaceutical company monitoring of adverse drug reactions. Drug Inf. J., 1985 20, 305–310

    Google Scholar 

  19. Garbus, S.B. et al. ADEMS: Astra drug experience monitoring system. Third World Conference on Clinical Pharmacology and Therapeutics, Stockholm, 1986, Abstract 411, p. 156

    Google Scholar 

  20. Anello, C. Management of ADR reports at the FDA. Drug Inf. J., 1985, 19, 291–294

    Google Scholar 

  21. Turner, W.M. FDA processing of ADR reports. Drug Inf. J., 1985, 19, 295–298

    Google Scholar 

  22. Brolund, G.V. The FDA adverse reaction report data base. Drug Inf. J., 1985, 19, 299–303

    Google Scholar 

  23. National Adverse Drug Reaction Directory COSTART (Coding Symbols for Thesaurus of Adverse Reaction Terms), US Dept. of Health, Education and Welfare, F.D.A

    Google Scholar 

  24. COSTART (Coding Symbols for Thesaurus of Adverse Reactions Terms), 2nd edition, Dept. of Health and Human Services, FDA, 1985

    Google Scholar 

  25. Streichenwein, S.M. Actual aspects of data integration — a view from an international company. Drug Inf. J., 1986, 20, 301–304

    Google Scholar 

  26. WHO International Classification of Diseases. Manual of the International Statistics Classification of Diseases, Injuries and Causes of Death, vols 1 and 2, Alphabetical index, 9th revision (1975), HMSO, 1977

    Google Scholar 

  27. National Library of Medicine, Bethesda, Medical Subject Headings (MeSH). Annotated alphabetical list, 1986

    Google Scholar 

  28. Perry, J. (ed.). OXMIS Problem Codes, Oxmis Publications, Oxford, 1978

    Google Scholar 

  29. Perry, J. A primary care morbidity code based on the international classification of diseases. In Medical Data Processing (ed. M. Laudet, J. Anderson and F. Bregon), Taylor and Francis, 1976, pp. 719–725

    Google Scholar 

  30. Côté, R.A. (ed.). Systematised Nomenclature of Medicine (SNOMED), vol. I, 2nd edition, College of American Pathologists, 1979 (numeric index)

    Google Scholar 

  31. Côté, R.A. (ed.). Systematised Nomenclature of Medicine (SNOMED), vol. II, 2nd edition, College of American Pathologists, 1979 (alphabetic index)

    Google Scholar 

  32. Côté, R.A. and Robboy, S. Progress in medical information management. Systematised Nomenclature of Medicine (SNOMED). J.A.M.A., 1980 243, 756–762

    Article  Google Scholar 

  33. Anon. International monitoring of adverse reactions to drugs. Adverse reaction terminology 1980. Collaborating Centre for International Drug Monitoring, Uppsala, Sweden

    Google Scholar 

  34. Saltzman, A. Adverse reaction terminology standardisation: A report on Schering-Plough’s use of the WHO Dictionary and the formation of the WHO adverse reaction terminology user’s group (WUG) consortium. Drug Inf. J., 1985, 19, 35–41

    Google Scholar 

  35. Herman, R.L. System integration of an adverse experience thesaurus — experience with a new computer methodology. Drug Inf. J., 1986, 20, 351–355

    Google Scholar 

  36. Monthly Index of Medical Specialities (MIMS). Haymarket Publishing, London (published monthly)

    Google Scholar 

  37. British National Formulary, No. 12, 1986. Pharmaceutical Press, London (updated 6-monthly)

    Google Scholar 

  38. Dendy, P.R. Indexing Medicines for Monitoring Adverse Reactions. Oxford Drug Monitoring Conference — Workshop on Drug Information System, 1977, Oxford Community Health Project, A1–A4

    Google Scholar 

  39. Dunleavy, J. and Perry, J. Appendix B. In OXMIS Problem Codes and Drug Codes (ed. J. Perry), Oxmis Publications, Oxford, 1978, B24–B25

    Google Scholar 

  40. Strathman, I. Experience with the WHO adverse reaction terminology at Searle. Drug Info. J., 1986, 20, 179–186

    Google Scholar 

  41. Walker, S.R. and Lumley, C.E. Reporting and under-reporting. In Adverse Drug Reactions (ed. R. Mann), Parthenon Publishing, 1987, pp. 115–126

    Google Scholar 

  42. McDevitt, D.G., Beardon, P.H.G. and Brown, S.V. Record linkage in Tayside: an assessment of present development. In Adverse Drug Reactions (ed. R. Mann), Parthenon Publishing, 1987, pp. 107–114

    Google Scholar 

  43. Lawson, D.H. Post-marketing surveillance: the problems in practice. In Adverse Drug Reactions (ed. R. Mann), Parthenon Publishing, 1987, pp. 159–164

    Google Scholar 

  44. Myers, M.G., Cairns, J.A. and Singer, J. The consent form as a possible cause of side effects. Clin. Pharmacol. Ther., 1987, 42, 250–253

    Article  Google Scholar 

  45. Levine, R.J. The apparent incompatibility between informed consent and placebo-controlled clinical trials. Clin. Pharmacol. Ther., 1987, 42, 247–248

    Article  Google Scholar 

  46. Chalmers, D., Dombey, S.L. and Lawson, D.H. Post-marketing surveillance of Captopril (for hypertension): a preliminary report. Br. J. Clin. Pharmac., 1987, 24, 343–349

    Article  Google Scholar 

  47. Barnett, D.B. and Woods, K.L. Post-marketing surveillance or drug acceptability study? Br. J. Clin. Pharmac., 1987, 24, 281–282

    Article  Google Scholar 

Download references

Authors
  1. M. D. B. Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 1988 M.D.B. Stephens

About this chapter

Cite this chapter

Stephens, M.D.B. (1988). The Collection, Storage, Retrieval and Management of Adverse Drug Reaction Data and Adverse Event Data. In: The Detection of New Adverse Drug Reactions. Palgrave, London. https://doi.org/10.1007/978-1-349-09887-3_9

Download citation

Publish with us

Policies and ethics

Search

Navigation